Please try using other words for your search or explore other sections of the website for relevant information.
Our team is working diligently to resolve the issue. Thank you for your patience and understanding.
Exclusive content, detailed data sets, and best-in-class trade insights to rewrite your portfolio for tomorrow.
Try it NowAugust 06, 2024 — 9:15 AM - 9:45 AM ET
Nasdaq MarketSite, 4 Times Square, New York
Neurogene Inc. (NASDAQ: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, visits the Nasdaq MarketSite in Times Square.
In honor of the occasion, Rachel McMinn, Ph.D., Founder and Chief Executive Officer, rings the Opening Bell.
